Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple sclerosis have limited effects on disability accrual unrelated to relapses, which is thought to be partially...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2025
|
| Sorozat: | NEW ENGLAND JOURNAL OF MEDICINE
392 No. 19 |
| Tárgyszavak: | |
| doi: | 10.1056/NEJMoa2415988 |
| mtmt: | 36149435 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/36778 |